American Herbal Products Association (AHPA) > News > Alerts

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe >>

View recent alerts:

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

Webinar: Adverse Event Reports (AERs) and Recalls of Dietary Supplements

In-depth review of AER requirements and recent AER and recall data and trends

Dr. Rick Kingston, an industry expert with more than 35-years of experience, presents on serious adverse event report (SAER) data and observations. Ashish Talati, a partner with Amin Talati & Wasserman and one of the industry’s foremost experts on FDA regulatory matters, joins Dr. Kingston to review dietary supplement legal and regulatory SAER obligations. In addition, AHPA Chief Information Officer Dr. Merle Zimmermann presents an overview of recent FDA recall data.

Guidance: Federal Labeling Requirements for Herbal Dietary Supplements

Updated to reflect changes from May 2016 Final Rule revising FDA’s nutrition labeling regulations

AHPA has revised it's labeling guidance for herbal dietary supplements to cover updated nutrition labeling requirements for foods and dietary supplements that are scheduled to take effect January 1, 2020 for manufacturers with $10 million or more in annual sales and January 1, 2021 for smaller manufacturers.

AHPA presents at the AOAC INTERNATIONAL 133rd Annual Meeting & Exposition

Michael McGuffin and Holly Johnson, Ph.D. outline ways AOAC analytical methods can support the herbal supplement industry

AHPA President Michael McGuffin and Chief Science Officer Holly Johnson, Ph.D. presented at the AOAC International 133rd Annual Meeting and Exposition to help the organization further develop analytical methods for botanicals used in herbal supplements.
Dietary supplement recalls are relatively infrequent according to recent FDA data

Dietary supplement recalls are relatively infrequent according to recent FDA data

Two percent of more than 800 recalls initiated in 2019 involved dietary supplement products

Recall data from the Food and Drug Administration (FDA) shows that 14 of 803 (1.7 percent) recorded recalls initiated in 2019 involved dietary supplements, and among these, three were Class I recalls (the most serious recall class), according to an article published in the August 2019 AHPA Report.
CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).
IADSA update on international supplement regulations

IADSA update on international supplement regulations

IADSA July 2019 Newsflash

China considers adding 5 functional ingredients, including reishi powder and spirulina, to its food raw materials directory, and changes to permitted health food function claims, in this issue of the IADSA Newsflash.

AHPA recommends FDA implement policies to support innovation

The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products.

Revised Hemp-CBD Status Report

July 11, 2019: How hemp and CBD companies are impacted by recent actions by the USDA and FDA

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

RSS
First 234567891011 Last

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.